Serac Healthcare Announces Successful FDA End of Phase II Meeting for Endometriosis Imaging Agent – Positive Feedback on Phase III Trial Design – By SH-Login Serac Healthcare Announces Successful FDA End of Phase II Meeting for Endometriosis Imaging Agent – Positive Feedback on Phase III Trial Design – Read More »
DETECT abstract accepted at World Congress on Endometriosis 2025 By SH-Login DETECT abstract accepted at World Congress on Endometriosis 2025 Read More »
DETECT Endometriosis Imaging Study Presented at EANM’24 By SH-Login DETECT Endometriosis Imaging Study Presented at EANM’24 Read More »
Poster Presented at MICCAI on AI Joint Classification of Images using 99mTc-Maraciclatide By SH-Login Poster Presented at MICCAI on AI Joint Classification of Images using 99mTc-Maraciclatide Read More »
EANM DETECT Abstract Published and Presentation Details By SH-Login EANM DETECT Abstract Published and Presentation Details Read More »
Phase II PREDICT-ILD Imaging Study Commences in Interstitial Lung Disease By SH-Login Phase II PREDICT-ILD Imaging Study Commences in Interstitial Lung Disease Read More »
Paper Accepted at MICCAI on AI Joint Classification of Images using ⁹⁹ᵐTc-Maraciclatide By SH-Login Paper Accepted at MICCAI on AI Joint Classification of Images using ⁹⁹ᵐTc-Maraciclatide Read More »
Abstract Selected as Top Rated Oral Presentation at EANM on DETECT Endometriosis Imaging Study By SH-Login Abstract Selected as Top Rated Oral Presentation at EANM on DETECT Endometriosis Imaging Study Read More »
⁹⁹ᵐTc-Maraciclatide Granted FDA Fast Track Designation for the Diagnosis of Superficial Peritoneal Endometriosis By SH-Login ⁹⁹ᵐTc-Maraciclatide Granted FDA Fast Track Designation for the Diagnosis of Superficial Peritoneal Endometriosis Read More »